Marc Stad’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-365,573
Closed -$4.19M 18
2026
Q1
$4.19M Sell
365,573
-291,862
-44% -$4.11M 0.14% 16
2025
Q4
$9.45M Sell
657,435
-688,719
-51% -$11.9M 0.21% 24
2025
Q3
$25.5M Hold
1,346,154
0.56% 20
2025
Q2
$28.9M Sell
1,346,154
-5,571,294
-81% -$82.8M 0.59% 17
2025
Q1
$90.7M Sell
6,917,448
-2,570,446
-27% -$38.2M 1.91% 16
2024
Q4
$128M Hold
9,487,894
2.23% 15
2024
Q3
$201M Sell
9,487,894
-3,238,105
-25% -$58.3M 3.5% 13
2024
Q2
$201M Hold
12,725,999
3.85% 13
2024
Q1
$189M Hold
12,725,999
4.38% 11
2023
Q4
$116M Buy
12,725,999
+4,576,137
+56% +$31.6M 2.53% 13
2023
Q3
$45.4M Hold
8,149,862
1.04% 19
2023
Q2
$65.7M Buy
8,149,862
+383,598
+5% +$2.83M 1.36% 18
2023
Q1
$50.8M Buy
7,766,264
+6,420,110
+477% +$26.2M 1.2% 19
2022
Q4
$3.31M Hold
1,346,154
0.1% 27
2022
Q3
$6.72M Hold
1,346,154
0.18% 26
2022
Q2
$5.72M Hold
1,346,154
0.15% 30
2022
Q1
$13.4M Sell
1,346,154
-1,197,687
-47% -$8.91M 0.17% 37
2021
Q4
$20M Hold
2,543,841
0.23% 41
2021
Q3
$44.2M Hold
2,543,841
0.58% 32
2021
Q2
$54.7M Hold
2,543,841
0.7% 31
2021
Q1
$68.4M Buy
+2,543,841
New +$79.6M 0.98% 27

Other funds holding OSCR

Marc Stad's OSCR Position: Q2 2026 in Review

Marc Stad sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 365,573 shares — an estimated $4.19M sold.

Marc Stad first reported a position in OSCR in Q1 2021 and held it in 21 quarters. The position peaked at $201M in Q2 2024. 401 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Marc Stad reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Marc Stad sold 365,573 Oscar Health shares in Q2 2026, an estimated $4.19M.
  • Marc Stad first reported a position in Oscar Health in Q1 2021 and held it in 21 quarters.
  • Marc Stad's Oscar Health position peaked at $201M in Q2 2024.
  • 401 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Dragoneer Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.